Scinai Immunotherapeutics (SCNI) EPS (Diluted) Growth (1y) (2018 - 2026)
Scinai Immunotherapeutics (SCNI) EPS (Diluted) Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 8.02% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -4.52% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 96.09% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 144.25% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 315.14% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -11.18% |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn | 45.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.66% |
| Jun 30, 2025 | 86.59% |
| Mar 31, 2025 | -104.26% |
| Dec 31, 2024 | 96.87% |
| Sep 30, 2024 | 14,261,329.04% |
| Jun 30, 2024 | -119.05% |
| Mar 31, 2024 | -39.88% |
| Dec 31, 2023 | 87.94% |
| Sep 30, 2023 | 88.95% |
| Jun 30, 2023 | -85.41% |
| Mar 31, 2023 | 175.34% |
| Dec 31, 2022 | -485.02% |
| Sep 30, 2022 | 100.00% |
| Jun 30, 2022 | 109.12% |
| Mar 31, 2022 | 91.00% |
| Dec 31, 2021 | 102.25% |
| Sep 30, 2021 | -109.12% |
| Mar 31, 2021 | 95.40% |
| Sep 30, 2020 | 313.92% |
| Mar 31, 2020 | -209.74% |